Sitalvi-M 50/ 500 (Sitagliptin/ Metformin 50/ 500 mg)
Drug Form: Tablet
It is used to treat type 2 diabetes, which has only the following benefits than sitagliptin:
- Effective reduction of hemoglobin A1c by using the complementary effect of sitagliptin and metformin.
- Better control of blood glucose in comparison to metformin monotherapy.
- Specific reduction in hypoglycemic attacks (hypoglycemia) in diabetic patients.
- Weight loss similar to metformin monotherapy